My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.49 -0.12 (-0.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,100 Today
 
Via Benzinga
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May. 
Via InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future. 
Via InvestorPlace
Smart Money Is Betting Big In MRNA Options
 
Via Benzinga
mRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it... 
Via Benzinga
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
These stocks aren't bargains. 
Via The Motley Fool
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Should You Buy Moderna Before May 12?
This ambitious biotech aims to launch 15 products over the coming five years. 
Via The Motley Fool
How Is The Market Feeling About Moderna?
 
Via Benzinga
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Many technology stocks are soaring, and you may be wondering if they've gotten too expensive. 
Via The Motley Fool
All In on Microsoft Stock: How AI Turned MSFT Into the Hottest Tech Play of 2024
Artificial Intelligence is moving Microsoft stock more than even the cloud did, CEO Satya Nadella said, with earnings to prove it. 
Via InvestorPlace
Topics Artificial Intelligence
What's Going On With Pfizer Stock On Thursday?
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S. 
Via Benzinga
Topics Intellectual Property
Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
Moderna began a collaboration with OpenAI in early 2023 with the launch of Moderna's own instance of ChatGPT, called mChat. The company said Wednesday that it has reached more than 80% internal... 
Via Benzinga
Topics Artificial Intelligence
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Via ACCESSWIRE
Moderna Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
Moderna Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
2 Stocks Down 30% to Buy Right Now
These stocks have plenty of catalysts ahead. 
Via The Motley Fool
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams. 
Via Benzinga
Topics Intellectual Property
Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy
With digital intelligence having the capability of advancing care, these are the medical AI stocks that long-term investors should consider. 
Via InvestorPlace
Topics Artificial Intelligence
REITs Q1 Earnings Begin On Solid Note
 
Via Benzinga
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
Via ACCESSWIRE
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Via ACCESSWIRE
$1000 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost... 
Via Benzinga
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners. 
Via The Motley Fool
Topics Artificial Intelligence
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
 
Via Benzinga
1 New Green Flag for Moderna and Merck Stock
There's a new reason to believe that their joint projects are going well. 
Via The Motley Fool
3 Pharma Stocks to Sell in April Before They Crash & Burn
Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside. 
Via InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments. 
Via InvestorPlace
Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans
Moderna pauses plans for Kenya vaccine plant amid declining COVID-19 vaccine demand in Africa. Losses from unfulfilled orders prompt strategic shift. Efforts to finalize deal with Kenyan government... 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.